Apelin is a positive regulator of ACE2 in failing hearts

Apelin/APJ Signaling Is a Critical Regulator of Statin Effects in Vascular Endothelial Cells—Brief Report

(2012) Danielle L. McLean et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The apelin receptor inhibits the angiotensin II type 1 receptor via allosteric trans-inhibition

(2012) K Siddiquee et al.   BRITISH JOURNAL OF PHARMACOLOGY

Angiotensin-converting enzyme 2, angiotensin-(1–7) and Mas: new players of the renin–angiotensin system

(2012) Robson A S Santos et al.   JOURNAL OF ENDOCRINOLOGY

ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation

(2012) Tatsuo Hashimoto et al.   NATURE

APJ acts as a dual receptor in cardiac hypertrophy

(2012) Maria Cecilia Scimia et al.   NATURE

The Aplnr GPCR regulates myocardial progenitor development via a novel cell-non-autonomous, G i/o protein-independent pathway

(2012) S. Paskaradevan et al.   Biology Open

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary

(2011) et al.   CIRCULATION

Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction

(2010) JiuChang Zhong et al.   CIRCULATION

Acute Cardiovascular Effects of Apelin in Humans

(2010) A.G. Japp et al.   CIRCULATION

Activation of catalase by apelin prevents oxidative stress-linked cardiac hypertrophy

(2010) Camille Foussal et al.   FEBS LETTERS

Coronary arteries form by developmental reprogramming of venous cells

(2010) Kristy Red-Horse et al.   NATURE

Trilogy of ACE2: A peptidase in the renin–angiotensin system, a SARS receptor, and a partner for amino acid transporters

(2010) Keiji Kuba et al.   PHARMACOLOGY & THERAPEUTICS

Endogenous regulation of cardiovascular function by apelin-APJ

(2009) David N. Charo et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Therapeutic Implications of the Vasoprotective Axis of the Renin-Angiotensin System in Cardiovascular Diseases

(2009) Anderson J. Ferreira et al.   HYPERTENSION

ACE2 Deficiency Modifies Renoprotection Afforded by ACE Inhibition in Experimental Diabetes

(2008) C. Tikellis et al.   DIABETES

Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis

(2008) Hyung J. Chun et al.   JOURNAL OF CLINICAL INVESTIGATION